"Our conversations with key opinion leaders in myelofibrosis indicated that they would like to see 20% for SVR35 and 30% TSS50 as the benchmark for a ‘good result’ in this patient population"
SNT Price at posting:
6.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)